Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Cash and Cash Equivalents, Period Increase (Decrease)

2.3 / 5 stars · 56/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Cash and Cash Equivalents, Period Increase (Decrease)

WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Cash and Cash Equivalents, Period Increase (Decrease) of $58.60 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-29.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-10-29

  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $69.30M, a 3.48% decline year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $61.20M, a 138.13% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$71.90M.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $40.10M.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $101.50M, a 208.51% increase from fiscal 2017.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $32.90M.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$71.60M, a 470.98% decline from fiscal 2015.
  • WEST PHARMACEUTICAL SERVICES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $19.30M, a 23.72% decline from fiscal 2014.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2019-09-30$69.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29
$130.50M
derived: sum of 2 quarters · filed 2019-10-29
$58.60M
10-Q · filed 2019-10-29
$98.70M
derived: sum of 4 quarters · filed 2019-10-29
2019-06-30$61.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29
-$10.70M
10-Q · filed 2019-07-29
$29.40M
derived: sum of 3 quarters · filed 2019-07-29
$101.20M
derived: sum of 4 quarters · filed 2019-10-29
2019-03-31-$71.90M
10-Q · filed 2019-05-08
-$31.80M
derived: sum of 2 quarters · filed 2019-05-08
$40.00M
derived: sum of 3 quarters · filed 2019-10-29
$65.70M
derived: sum of 4 quarters · filed 2019-10-29
2018-12-31$40.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$111.90M
derived: sum of 2 quarters · filed 2019-10-29
$137.60M
derived: sum of 3 quarters · filed 2019-10-29
$101.50M
10-K · filed 2019-02-28
2018-09-30$71.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29
$97.50M
derived: sum of 2 quarters · filed 2019-10-29
$61.40M
10-Q · filed 2019-10-29
$28.00M
derived: sum of 4 quarters · filed 2019-10-29
2018-06-30$25.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29
-$10.40M
10-Q · filed 2019-07-29
-$43.80M
derived: sum of 3 quarters · filed 2019-07-29
-$1.10M
derived: sum of 4 quarters · filed 2019-07-29
2018-03-31-$36.10M
10-Q · filed 2019-05-08
-$69.50M
derived: sum of 2 quarters · filed 2019-05-08
-$26.80M
derived: sum of 3 quarters · filed 2019-05-08
$30.40M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31-$33.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$9.30M
derived: sum of 2 quarters · filed 2019-02-28
$66.50M
derived: sum of 3 quarters · filed 2019-02-28
$32.90M
10-K · filed 2019-02-28
2017-09-30$42.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$99.90M
derived: sum of 2 quarters · filed 2018-10-30
$66.30M
10-Q · filed 2018-10-30
$63.40M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$57.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31
$23.60M
10-Q · filed 2018-07-31
$20.70M
derived: sum of 3 quarters · filed 2019-02-28
$23.90M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$33.60M
10-Q · filed 2018-05-08
-$36.50M
derived: sum of 2 quarters · filed 2019-02-28
-$33.30M
derived: sum of 3 quarters · filed 2019-02-28
-$8.70M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$300.00K
derived: sum of 2 quarters · filed 2019-02-28
$24.90M
derived: sum of 3 quarters · filed 2019-02-28
-$71.60M
10-K · filed 2019-02-28
2016-09-30$3.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$27.80M
derived: sum of 2 quarters · filed 2017-10-31
-$68.70M
10-Q · filed 2017-10-31
-$50.90M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$24.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
-$71.90M
10-Q · filed 2017-08-01
-$54.10M
derived: sum of 3 quarters · filed 2018-02-26
-$49.30M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$96.50M
10-Q · filed 2017-05-05
-$78.70M
derived: sum of 2 quarters · filed 2018-02-26
-$73.90M
derived: sum of 3 quarters · filed 2018-02-26
-$29.00M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$17.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$22.60M
derived: sum of 2 quarters · filed 2018-02-26
$67.50M
derived: sum of 3 quarters · filed 2018-02-26
$19.30M
10-K · filed 2018-02-26
2015-09-30$4.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31
$49.70M
derived: sum of 2 quarters · filed 2016-10-31
$1.50M
10-Q · filed 2016-10-31
$10.00M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$44.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01
-$3.30M
10-Q · filed 2016-08-01
$5.20M
derived: sum of 3 quarters · filed 2017-02-28
$25.30M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$48.20M
10-Q · filed 2016-05-06
-$39.70M
derived: sum of 2 quarters · filed 2017-02-28
-$19.60M
derived: sum of 3 quarters · filed 2017-02-28
-$22.90M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$8.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$28.60M
derived: sum of 2 quarters · filed 2017-02-28
$25.30M
derived: sum of 3 quarters · filed 2017-02-28
$25.30M
10-K · filed 2017-02-28
2014-09-30$20.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$16.80M
derived: sum of 2 quarters · filed 2015-11-02
$16.80M
10-Q · filed 2015-11-02
$25.10M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30-$3.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03
-$3.30M
10-Q · filed 2015-08-03
$5.00M
derived: sum of 3 quarters · filed 2016-02-26
$36.10M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$0.00
10-Q · filed 2015-05-06
$8.30M
derived: sum of 2 quarters · filed 2016-02-26
$39.40M
derived: sum of 3 quarters · filed 2016-02-26
$55.00M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$39.40M
derived: sum of 2 quarters · filed 2016-02-26
$55.00M
derived: sum of 3 quarters · filed 2016-02-26
$68.10M
10-K · filed 2016-02-26
2013-09-30$31.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03
$46.70M
derived: sum of 2 quarters · filed 2014-11-03
$59.80M
10-Q · filed 2014-11-03
$78.50M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30$15.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$28.70M
10-Q · filed 2014-08-01
$47.40M
derived: sum of 3 quarters · filed 2015-02-25
$83.60M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$13.10M
10-Q · filed 2014-05-08
$31.80M
derived: sum of 2 quarters · filed 2015-02-25
$68.00M
derived: sum of 3 quarters · filed 2015-02-25
$74.80M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31$18.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
$54.90M
derived: sum of 2 quarters · filed 2015-02-25
$61.70M
derived: sum of 3 quarters · filed 2015-02-25
$70.10M
10-K · filed 2015-02-25
2012-09-30$36.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
$43.00M
derived: sum of 2 quarters · filed 2013-11-04
$51.40M
10-Q · filed 2013-11-04
$24.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$6.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
$15.20M
10-Q · filed 2013-08-05
-$12.20M
derived: sum of 3 quarters · filed 2014-02-27
-$3.40M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$8.40M
10-Q · filed 2013-05-06
-$19.00M
derived: sum of 2 quarters · filed 2014-02-27
-$10.20M
derived: sum of 3 quarters · filed 2014-02-27
$5.60M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31-$27.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
-$18.60M
derived: sum of 2 quarters · filed 2014-02-27
-$2.80M
derived: sum of 3 quarters · filed 2014-02-27
-$18.40M
10-K · filed 2014-02-27
2011-09-30$8.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$24.60M
derived: sum of 2 quarters · filed 2012-11-05
$9.00M
10-Q · filed 2012-11-05
$22.10M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$15.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
$200.00K
10-Q · filed 2012-08-06
$13.30M
derived: sum of 3 quarters · filed 2013-02-27
$42.90M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31-$15.60M
10-Q · filed 2012-05-04
-$2.50M
derived: sum of 2 quarters · filed 2013-02-27
$27.10M
derived: sum of 3 quarters · filed 2013-02-27
$28.70M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$13.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$42.70M
derived: sum of 2 quarters · filed 2013-02-27
$44.30M
derived: sum of 3 quarters · filed 2013-02-27
$27.10M
10-K · filed 2013-02-27
2010-09-30$29.60M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07
$31.20M
derived: sum of 2 quarters · filed 2011-11-07
$14.00M
10-Q · filed 2011-11-07
$17.60M
derived: sum of 4 quarters · filed 2012-03-01
2010-06-30$1.60M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08
-$15.60M
10-Q/A · filed 2011-08-08
-$12.00M
derived: sum of 3 quarters · filed 2012-03-01
-$16.80M
derived: sum of 4 quarters · filed 2012-03-01
2010-03-31-$17.20M
10-Q · filed 2011-05-05
-$13.60M
derived: sum of 2 quarters · filed 2012-03-01
-$18.40M
derived: sum of 3 quarters · filed 2012-03-01
2009-12-31$3.60M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01
-$1.20M
derived: sum of 2 quarters · filed 2012-03-01
-$4.10M
10-K/A · filed 2012-03-01
2009-09-30-$4.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
-$7.70M
10-Q · filed 2010-11-05
2009-06-30-$2.90M
10-Q · filed 2010-08-05
2008-12-31-$21.20M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44